Angiotensin-Converting Enzyme Inhibitors

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Initially developed
    • June 1996
  • Revision history
    • January 22, 2021; December 2018; December 2016; December 2014; March 2013; April 2011; March 2011; April 2008; June 2003; July 2002; September 2001; June 2001; June 2000; July 1999; June 1998; June 1997